Foghorn Therapeutics raises ~$110M via public offering of common stock and pre-funded warrants

Foghorn Therapeutics Inc.

Sold 12,743,039 shares of common stock at $5.51/share and pre-funded warrants for 7,220,794 shares at $5.5099 each.
Gross proceeds estimated at ~$110M; pre-funded warrants are immediately exercisable with no expiration.
Offering closed on May 22, 2024; underwriters include Jefferies, TD Securities, and Evercore Group.
Pre-funded warrants include a 9.99% beneficial ownership cap, adjustable to up to 19.99% with 61 days' notice.
Filing made under effective shelf registration statement (Form S-3, File No. 333-262711).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.